Selected research
Industry Research
Cold Chain Services for Innovative Drug Industry Research Report 2026
Market perspective
The global Cold Chain Services for Innovative Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cold Chain Services for Innovative Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cold Chain Services for Innovative Drug market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cold Chain Services for Innovative Drug market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cold Chain Services for Innovative Drug include Marken, World Courier, Cryoport, DTW Logistics, City Express, Shanghai Shengsheng Pharmaceutical Cold Chain Technology, Thermo Fisher, SF Express and Catalent, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cold Chain Services for Innovative Drug market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cold Chain Services for Innovative Drug.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cold Chain Services for Innovative Drug Market by Company
Marken
World Courier
Cryoport
DTW Logistics
City Express
Shanghai Shengsheng Pharmaceutical Cold Chain Technology
Thermo Fisher
SF Express
Catalent
CIMC Cold Cloud
Guoyuan Life Sciences Group
Rochin Logistics
Azenta
Saroute
Cold Chain Services for Innovative Drug Segment by Type
International Transportation
Domestic Transportation
Cold Chain Services for Innovative Drug Segment by Application
Pharmaceutical Companies
Hospitals
Laboratories
Others
Cold Chain Services for Innovative Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cold Chain Services for Innovative Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cold Chain Services for Innovative Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cold Chain Services for Innovative Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cold Chain Services for Innovative Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- International Transportation
- Domestic Transportation
Applications
- Pharmaceutical Companies
- Hospitals
- Laboratories
- Others
Companies covered
- Marken
- World Courier
- Cryoport
- DTW Logistics
- City Express
- Shanghai Shengsheng Pharmaceutical Cold Chain Technology
- Thermo Fisher
- SF Express
- Catalent
- CIMC Cold Cloud
- Guoyuan Life Sciences Group
- Rochin Logistics
- Azenta
- Saroute
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cold Chain Services for Innovative Drug by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 International Transportation
- 2.2.3 Domestic Transportation
- 2.3 Cold Chain Services for Innovative Drug by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Hospitals
- 2.3.4 Laboratories
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Cold Chain Services for Innovative Drug Breakdown Data by Type
- 3.1 Global Cold Chain Services for Innovative Drug Historic Market Size by Type (2021-2026)
- 3.2 Global Cold Chain Services for Innovative Drug Forecasted Market Size by Type (2027-2032)
4 Cold Chain Services for Innovative Drug Breakdown Data by Application
- 4.1 Global Cold Chain Services for Innovative Drug Historic Market Size by Application (2021-2026)
- 4.2 Global Cold Chain Services for Innovative Drug Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cold Chain Services for Innovative Drug Market Perspective (2021-2032)
- 5.2 Global Cold Chain Services for Innovative Drug Growth Trends by Region
- 5.2.1 Global Cold Chain Services for Innovative Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cold Chain Services for Innovative Drug Historic Market Size by Region (2021-2026)
- 5.2.3 Cold Chain Services for Innovative Drug Forecasted Market Size by Region (2027-2032)
- 5.3 Cold Chain Services for Innovative Drug Market Dynamics
- 5.3.1 Cold Chain Services for Innovative Drug Industry Trends
- 5.3.2 Cold Chain Services for Innovative Drug Market Drivers
- 5.3.3 Cold Chain Services for Innovative Drug Market Challenges
- 5.3.4 Cold Chain Services for Innovative Drug Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cold Chain Services for Innovative Drug Players by Revenue
- 6.1.1 Global Top Cold Chain Services for Innovative Drug Players by Revenue (2021-2026)
- 6.1.2 Global Cold Chain Services for Innovative Drug Revenue Market Share by Players (2021-2026)
- 6.2 Global Cold Chain Services for Innovative Drug Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cold Chain Services for Innovative Drug Head Office and Area Served
- 6.4 Global Cold Chain Services for Innovative Drug Players, Product Type & Application
- 6.5 Global Cold Chain Services for Innovative Drug Manufacturers Established Date
- 6.6 Global Cold Chain Services for Innovative Drug Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cold Chain Services for Innovative Drug Market Size (2021-2032)
- 7.2 North America Cold Chain Services for Innovative Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cold Chain Services for Innovative Drug Market Size by Country (2021-2026)
- 7.4 North America Cold Chain Services for Innovative Drug Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cold Chain Services for Innovative Drug Market Size (2021-2032)
- 8.2 Europe Cold Chain Services for Innovative Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cold Chain Services for Innovative Drug Market Size by Country (2021-2026)
- 8.4 Europe Cold Chain Services for Innovative Drug Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cold Chain Services for Innovative Drug Market Size (2021-2032)
- 9.2 Asia-Pacific Cold Chain Services for Innovative Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cold Chain Services for Innovative Drug Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cold Chain Services for Innovative Drug Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cold Chain Services for Innovative Drug Market Size (2021-2032)
- 10.2 South America Cold Chain Services for Innovative Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cold Chain Services for Innovative Drug Market Size by Country (2021-2026)
- 10.4 South America Cold Chain Services for Innovative Drug Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cold Chain Services for Innovative Drug Market Size (2021-2032)
- 11.2 Middle East & Africa Cold Chain Services for Innovative Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cold Chain Services for Innovative Drug Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Marken
- 12.1.1 Marken Company Information
- 12.1.2 Marken Business Overview
- 12.1.3 Marken Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.1.4 Marken Cold Chain Services for Innovative Drug Product Portfolio
- 12.1.5 Marken Recent Developments
- 12.2 World Courier
- 12.2.1 World Courier Company Information
- 12.2.2 World Courier Business Overview
- 12.2.3 World Courier Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.2.4 World Courier Cold Chain Services for Innovative Drug Product Portfolio
- 12.2.5 World Courier Recent Developments
- 12.3 Cryoport
- 12.3.1 Cryoport Company Information
- 12.3.2 Cryoport Business Overview
- 12.3.3 Cryoport Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.3.4 Cryoport Cold Chain Services for Innovative Drug Product Portfolio
- 12.3.5 Cryoport Recent Developments
- 12.4 DTW Logistics
- 12.4.1 DTW Logistics Company Information
- 12.4.2 DTW Logistics Business Overview
- 12.4.3 DTW Logistics Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.4.4 DTW Logistics Cold Chain Services for Innovative Drug Product Portfolio
- 12.4.5 DTW Logistics Recent Developments
- 12.5 City Express
- 12.5.1 City Express Company Information
- 12.5.2 City Express Business Overview
- 12.5.3 City Express Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.5.4 City Express Cold Chain Services for Innovative Drug Product Portfolio
- 12.5.5 City Express Recent Developments
- 12.6 Shanghai Shengsheng Pharmaceutical Cold Chain Technology
- 12.6.1 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Company Information
- 12.6.2 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Business Overview
- 12.6.3 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.6.4 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Cold Chain Services for Innovative Drug Product Portfolio
- 12.6.5 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Recent Developments
- 12.7 Thermo Fisher
- 12.7.1 Thermo Fisher Company Information
- 12.7.2 Thermo Fisher Business Overview
- 12.7.3 Thermo Fisher Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.7.4 Thermo Fisher Cold Chain Services for Innovative Drug Product Portfolio
- 12.7.5 Thermo Fisher Recent Developments
- 12.8 SF Express
- 12.8.1 SF Express Company Information
- 12.8.2 SF Express Business Overview
- 12.8.3 SF Express Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.8.4 SF Express Cold Chain Services for Innovative Drug Product Portfolio
- 12.8.5 SF Express Recent Developments
- 12.9 Catalent
- 12.9.1 Catalent Company Information
- 12.9.2 Catalent Business Overview
- 12.9.3 Catalent Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.9.4 Catalent Cold Chain Services for Innovative Drug Product Portfolio
- 12.9.5 Catalent Recent Developments
- 12.10 CIMC Cold Cloud
- 12.10.1 CIMC Cold Cloud Company Information
- 12.10.2 CIMC Cold Cloud Business Overview
- 12.10.3 CIMC Cold Cloud Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.10.4 CIMC Cold Cloud Cold Chain Services for Innovative Drug Product Portfolio
- 12.10.5 CIMC Cold Cloud Recent Developments
- 12.11 Guoyuan Life Sciences Group
- 12.11.1 Guoyuan Life Sciences Group Company Information
- 12.11.2 Guoyuan Life Sciences Group Business Overview
- 12.11.3 Guoyuan Life Sciences Group Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.11.4 Guoyuan Life Sciences Group Cold Chain Services for Innovative Drug Product Portfolio
- 12.11.5 Guoyuan Life Sciences Group Recent Developments
- 12.12 Rochin Logistics
- 12.12.1 Rochin Logistics Company Information
- 12.12.2 Rochin Logistics Business Overview
- 12.12.3 Rochin Logistics Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.12.4 Rochin Logistics Cold Chain Services for Innovative Drug Product Portfolio
- 12.12.5 Rochin Logistics Recent Developments
- 12.13 Azenta
- 12.13.1 Azenta Company Information
- 12.13.2 Azenta Business Overview
- 12.13.3 Azenta Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.13.4 Azenta Cold Chain Services for Innovative Drug Product Portfolio
- 12.13.5 Azenta Recent Developments
- 12.14 Saroute
- 12.14.1 Saroute Company Information
- 12.14.2 Saroute Business Overview
- 12.14.3 Saroute Revenue in Cold Chain Services for Innovative Drug Business (2021-2026)
- 12.14.4 Saroute Cold Chain Services for Innovative Drug Product Portfolio
- 12.14.5 Saroute Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst